The latest installment in the long-running Resident Evil cinematic franchise has stormed the North American box office, signaling a massive revitalization for the series. Directed by Zach Cregger, the new adaptation of the iconic survival-horror video game property grossed $26.3 million on its opening Friday, a figure bolstered by a robust $8.8 million in Thursday preview screenings. Industry analysts at Sony Pictures are now projecting a weekend haul between $53 million and $55 million, though mid-weekend tracking suggests that momentum could push the final tally toward an impressive $60 million. This performance not only positions the film as the strongest debut in the history of the franchise but also marks a significant victory for a production that carried a relatively modest $75 million budget.
A Franchise Reimagined
The Resident Evil franchise has long been a staple of the horror-action genre. The series began in 2002 under the direction of Paul W.S. Anderson, with Milla Jovovich anchoring the lead role of Alice through six installments. Collectively, these films amassed over $1.2 billion in worldwide box office receipts. However, the 2021 soft reboot, Resident Evil: Welcome to Raccoon City, failed to resonate with critics and audiences, stalling the momentum of the IP.
The current project, helmed by Cregger—who previously directed the 2025 Oscar-winning film Weapons—represents a pivot toward a more critically acclaimed aesthetic. By securing a 96 percent approval rating on Rotten Tomatoes, the film has achieved a rare feat for a horror-game adaptation, becoming the highest-reviewed entry in the franchise to date. Audiences have mirrored this sentiment, awarding the film a B+ CinemaScore and a 92 percent positive audience rating, suggesting strong word-of-mouth potential for the coming weeks.
The Financial Landscape and Strategic Rollout
Opening across 3,684 domestic theaters, the film’s $53-60 million estimate represents a significant departure from Sony’s conservative initial projections, which hovered around the $40 million mark. This delta reflects both the power of the Resident Evil brand and the growing cultural cachet of Zach Cregger as a filmmaker. Following the $43.5 million debut of his previous project, Weapons, this latest opening cements Cregger’s status as a commercial force in the studio system.
The film, produced through a collaboration between TriStar Pictures, Constantin Film, and Davis Film, follows the journey of a medical courier, played by Austin Abrams, who finds himself entangled in a viral catastrophe within the claustrophobic confines of Raccoon City. The supporting cast, which includes Zach Cherry, Kali Reis, and Paul Walter Hauser, has been lauded for grounding the high-concept horror in human stakes. In his review for The Hollywood Reporter, critic Frank Scheck highlighted the film’s balance of technical proficiency and genre subversion, noting that Cregger successfully navigated the delicate line between "propulsive, terrifying" action and a distinctly "perverse sense of humor."
Box Office Context: A Competitive Market
While Resident Evil dominates the headlines, the broader theatrical landscape remains robust. The sophomore frame for Warner Bros.’ Practical Magic 2 has settled into second place. Despite a projected 65 percent drop, the sequel starring Sandra Bullock and Nicole Kidman is set to gross $10.4 million, bringing its domestic total to approximately $48.2 million. This performance is noteworthy as it has already eclipsed the total domestic run of the 1998 original, which finished with $46.7 million.
In third place, Sony’s Spider-Man: Brand New Day continues its historic trajectory. Now in its eighth weekend, the film is expected to add $6.3 million to its domestic total, pushing it to an eye-watering $944.3 million. The industry is currently watching to see if the blockbuster, directed by the Tom Holland-led team, can become the first film in history to cross the $1 billion threshold domestically. This record-breaking run has effectively redefined expectations for post-pandemic theatrical endurance.
Meanwhile, Christopher Nolan’s The Odyssey, distributed by Universal, continues to display remarkable stamina in its 10th week of release. With an estimated $5 million weekend, the film has solidified its position as Universal’s highest-grossing title in history, reaching a domestic cumulative gross of $609.8 million. Rounding out the top five is the resilient Ketchup Entertainment release, Coyote vs. Acme. The film, which famously survived a near-cancellation as a tax write-off, is expected to add $4.2 million, bringing its domestic total to roughly $54.5 million—a testament to its enduring appeal with family audiences.
Niche Success and Anniversary Rereleases
Beyond the top five, the marketplace has seen a diverse array of offerings. Fathom Entertainment’s 40th-anniversary rerelease of the 1986 animated classic, The Transformers: The Movie, drew in $2.95 million, signaling the continued viability of "event" cinema for dedicated fan bases.
Furthermore, the animation sector saw a unique entry with the release of Shaun the Sheep: The Beast of Mossy Bottom. Produced by StudioCanal and Aardman and distributed by GKIDS, the film earned a B+ CinemaScore and is expected to gross $1.4 million across 2,173 locations. This release is particularly notable for marking a rare calendar year in which two major sheep-centric features—following May’s The Sheep Detectives—have held wide releases in North American theaters.
Implications for the Industry
The success of Resident Evil provides several key takeaways for the modern film industry. First, the film’s critical success proves that video game adaptations, once considered a "cursed" sub-genre, are now a primary vehicle for box office growth. Second, the performance of films like The Odyssey and Spider-Man: Brand New Day suggests that long-tail theatrical runs are still possible in the era of streaming, provided the content is perceived as a "must-see" cultural event.
For Sony Pictures, the results underscore the effectiveness of their recent slate strategy, which emphasizes a mix of legacy IP, high-budget superhero spectacle, and targeted genre horror. As the industry moves into the late-year cycle, the question remains whether the momentum generated by the current crop of releases will hold. With Resident Evil performing at the top end of expectations, it is highly probable that the studio will fast-track a sequel, potentially turning the franchise toward a new era of box office dominance.
The interplay between established hits and new breakouts reflects a healthy, if competitive, environment. As theaters look to maintain the gains made throughout 2026, the success of a diverse range of films—from stop-motion animation to high-concept horror and record-shattering superhero epics—indicates a resilient and evolving audience appetite for the big-screen experience. The coming weeks will be critical in determining the final ceiling for these films, but for now, the theatrical sector appears to be in a period of sustained, high-level performance.
